NDC 70199-021

HELIDAC Therapy

Bismuth Subsalicylate Chewable Tablets/metronidazole Tablets/tetracycline Hydrochloride Capsules

HELIDAC Therapy is a Kit in the Human Prescription Drug category. It is labeled and distributed by Casper Pharma Llc. The primary component is .

Product ID70199-021_ea33e2ed-b75c-457e-bbf0-0604c59d302b
NDC70199-021
Product TypeHuman Prescription Drug
Proprietary NameHELIDAC Therapy
Generic NameBismuth Subsalicylate Chewable Tablets/metronidazole Tablets/tetracycline Hydrochloride Capsules
Dosage FormKit
Marketing Start Date2020-06-11
Marketing CategoryANDA / ANDA
Application NumberANDA202584
Labeler NameCasper Pharma LLC
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 70199-021-14

14 BLISTER PACK in 1 CARTON (70199-021-14) > 4 PACKAGE in 1 BLISTER PACK > 1 KIT in 1 PACKAGE
Marketing Start Date2020-06-11
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "HELIDAC Therapy" or generic name "Bismuth Subsalicylate Chewable Tablets/metronidazole Tablets/tetracycline Hydrochloride Capsules"

NDCBrand NameGeneric Name
70199-021HELIDAC TherapyBismuth Subsalicylate Chewable Tablets/Metronidazole Tablets/Tetracycline Hydrochloride Capsules
70556-103Bismuth Subsalicylate/Metronidazole/Tetracycline HydrochlorideBismuth Subsalicylate Chewable Tablets/Metronidazole Tablets/Tetracycline Hydrochloride Capsules
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.